Preventing Cytomegalovirus Infection in High-Risk Bone Marrow Transplant Patients

In this CME-certified interactive presentation, Kathleen Mullane, DO, PharmD, provides expert perspectives on optimal strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.
Kathleen Mullane, DO, PharmD
Released: December 13, 2017 Expiration: No longer available for credit

Related Content

Phase III BMT CTN 1703 trial of cyclophosphamide, tacrolimus, and mycophenolate mofetil for prevention of GVHD following alloSCT, presented at ASH 2022 and reported by Clinical Care Options (CCO)

Released: December 15, 2022

GVHD experts address key questions about the treatment of patients with graft versus host disease in this commentary from Clinical Care Options (CCO)

Corey Cutler, MD, MPH, FRCPC Released: May 4, 2022

Expert-selected summary slides on graft-versus-host disease to help diagnose and manage your patients with GVHD, from Clinical Care Options (CCO).

Corey Cutler, MD, MPH, FRCPC David Miklos, MD, PhD Robert Zeiser, MD Released: February 8, 2022

On-demand Clinical Care Options (CCO) webcast: expert faculty discuss treatment options for B-cell lymphomas, including updates from ASH 2021

Julie M. Vose, MD, MBA
Program Director
Brad S. Kahl, MD John P. Leonard, MD
Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: February 7, 2022 Expired: February 6, 2023


Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings